Table 1.
Parameters of inflammation | Non-heat-acclimated status | Heat-acclimated status | Main effect (F) | P value | ||
---|---|---|---|---|---|---|
Before EC test | After EC test | Before EC test | After EC test | |||
hsCRP mg/L |
0.63 ± 0.52 | 1.04 ± 0.89* | 1.17 ± 2.59 | 3.53 ± 4.64* | 5.97 | 0.010 |
| ||||||
loghsCRP mg/L |
−0.32 ± 0.32 | − 0.12 ± 0.34* | − 0.31 ± 0.47 | 0.28 ± 0.46*** | 14.76 | 0.000 |
| ||||||
sICAM-1 ng/mL |
163.62 ± 29.62 | 169.20 ± 30.79 | 164.48 ± 28.17 | 169.22 ± 27.31 | 0.95 | 0.402 |
| ||||||
WBC ×109/L |
5.33 ± 1.13 | 5.68 ± 1.42 | 5.30 ± 1.08 | 5.72 ± 1.22 | 1.72 | 0.173 |
| ||||||
EGF pg/mL |
2.81 ± 1.99 | 3.19 ± 2.26 | 3.31 ± 2.33 | 2.46 ± 1.77 | 2.16 | 0.124 |
| ||||||
VEGF pg/mL |
53.14 ± 45.04 | 54.99 ± 36.04 | 54.87 ± 35.89 | 45.87 ± 29.38 | 1.16 | 0.325 |
| ||||||
MCP-1 protein-1 pg/mL |
157.52 ± 76.74 | 148.64 ± 60.20 | 187.79 ± 76.37 | 138.36 ± 58.05*** | 6.10 | 0.001 |
| ||||||
IL-6 pg/mL |
0.78 ± 0.67 | 0.92 ± 0.67 | 1.11 ± 1.51 | 0.90 ± 0.93 | 0.93 | 0.433 |
| ||||||
IL-8 pg/mL |
8.55 ± 12.25 | 9.93 ± 17.48 | 9.92 ± 13.05 | 8.30 ± 12.63 | 2.11 | 0.152 |
| ||||||
β2M μg/L |
1478.29 ± 217.79 | 1465.42 ± 204.64 | 1453.24 ± 213.02 | 1528.18 ± 280.28 | 1.73 | 0.538 |
Note: EC: endurance capacity; hsCRP: high-sensitive C-reactive protein; sICAM-1: soluble intercellular adhesion molecule-1; WBC: white blood cells; EGF: epidermal growth factor; VEGF: vascular endothelial growth factor; MCP-1: monocyte chemoattractant protein-1; IL-6: interleukin-6; IL-8: interleukin-8; β2M: β 2-microglobulin; *P < 0.05; ***P < 0.001 as compared to value measured before EC test.